ORAGENICS INC·4

Dec 15, 4:38 PM ET

Telling Fred 4

4 · ORAGENICS INC · Filed Dec 15, 2025

Insider Transaction Report

Form 4
Period: 2025-12-11
Telling Fred
Director
Transactions
  • Sale

    Common Stock

    2025-12-12$0.94/sh210$19834,538 total
  • Award

    Non-Employee Director Option (Right to Buy)

    2025-12-11+125,000125,000 total
    Exercise: $0.93From: 2025-12-11Exp: 2035-12-11Common Stock (125,000 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $0.9440 to $0.9451. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F2]Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT